PHG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Given the user's beginner investment knowledge, long-term preference, and available capital, Koninklijke Philips NV (PHG) is not a strong buy at this moment. The stock is experiencing negative pre-market movement (-2.39%), technical indicators are weak, and hedge funds are selling significantly. While there are positive developments in product innovation and sustainability, the company's financial performance shows a concerning drop in net income and EPS. Analysts maintain neutral ratings with limited upside potential. Therefore, holding off on buying is recommended until stronger positive signals emerge.
The MACD is negative and expanding (-0.238), RSI is neutral at 30.262, and moving averages are converging, indicating no clear trend. The stock is trading near its support level (S1: 29.8), with resistance at 30.883. Current pre-market price is 28.95, below key support levels, suggesting potential downside risk.
Philips has launched new innovative products, including the Sonicare toothbrush and Rembra CT system, and initiated the SHERPA AI research project with a significant budget of EUR 21.5 million, showcasing its focus on technology and sustainability.
Hedge funds are aggressively selling the stock (+30126.47% increase in selling activity last quarter). Additionally, the company faces ongoing regulatory and execution concerns as highlighted by analysts. Pre-market price is down 2.39%, and financial performance shows a sharp decline in net income and EPS.
In Q4 2025, revenue grew by 10.32% YoY to EUR 5.93 billion, but net income dropped by -228.70% YoY to EUR 459.79 million. EPS also declined by -226.32% YoY to 0.48. Gross margin improved to 44.88%, up 15.31% YoY, but the sharp drop in profitability is a major concern.
Analysts maintain neutral ratings with limited upside potential. Recent price target changes include EUR 26 from Morgan Stanley (Equal Weight), EUR 22.60 from JPMorgan (Neutral), and EUR 25 from Citi (Neutral). Goldman Sachs recently removed Philips from its European Conviction List, reflecting cautious sentiment.
